{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:50:59Z","timestamp":1790121059480,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.4158\/ep-2018-0328","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T15:47:07Z","timestamp":1541087227000},"page":"23-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Efficacy and Safety of Bisphosphonate Therapy in Mccune-Albright Syndrome\u2013Related Polyostotic Fibrous Dysplasia: A Single-Center Experience"],"prefix":"10.1016","volume":"25","author":[{"given":"Yabing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibo","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunwu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 2","key":"10.4158\/EP-2018-0328_bb0010","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1359\/jbmr.06s223","article-title":"G(s)alpha mutations in fibrous dysplasia and McCune-Albright syndrome","volume":"21","author":"Weinstein","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP-2018-0328_bb0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-1172-3-12","article-title":"McCune-Albright syndrome","volume":"3","author":"Dumitrescu","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"10.4158\/EP-2018-0328_bb0020","series-title":"GeneReviews","article-title":"Fibrous dysplasia\/McCune-Albright syndrome","author":"Boyce","year":"1993"},{"key":"10.4158\/EP-2018-0328_bb0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/1477-7819-12-349","article-title":"En bloc resection and bone graft: does it alter the natural history of monostotic expansile fibrous dysplasia in children?","volume":"12","author":"Li","year":"2014","journal-title":"World J Surg Oncol"},{"key":"10.4158\/EP-2018-0328_bb0030","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2106\/JBJS.O.00547","article-title":"Bone-grafting in polyostotic fibrous dysplasia","volume":"98","author":"Leet","year":"2016","journal-title":"J Bone Joint Surg Am"},{"key":"10.4158\/EP-2018-0328_bb0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1096-9896(199901)187:2<249::AID-PATH222>3.0.CO;2-J","article-title":"The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks","volume":"187","author":"Riminucci","year":"1999","journal-title":"J Pathol"},{"key":"10.4158\/EP-2018-0328_bb0040","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0002-9343(68)90112-5","article-title":"Fibrous dysplasia of the bone. Review of twenty-four cases","volume":"44","author":"Firat","year":"1968","journal-title":"Am J Med"},{"key":"10.4158\/EP-2018-0328_bb0045","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0140-6736(94)90069-8","article-title":"Long-term effects of intravenous pamidronate in fibrous dysplasia of bone","volume":"343","author":"Liens","year":"1994","journal-title":"Lancet"},{"key":"10.4158\/EP-2018-0328_bb0050","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bone.2004.03.004","article-title":"Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment","volume":"35","author":"Chapurlat","year":"2004","journal-title":"Bone"},{"key":"10.4158\/EP-2018-0328_bb0055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00223-001-1098-7","article-title":"Bone turnover in children and adolescents with McCune-Albright syndrome treated with pamidronate for bone fibrous dysplasia","volume":"71","author":"Isaia","year":"2002","journal-title":"Calcif Tissue Int"},{"issue":"suppl 2","key":"10.4158\/EP-2018-0328_bb0060","first-page":"583","article-title":"Bisphosphonate treatment of bone fibrous dysplasia in McCune-Albright syndrome","volume":"19","author":"Lala","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.4158\/EP-2018-0328_bb0065","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s00223-013-9829-0","article-title":"Clinical and radiological observations in a case series of 26 patients with fibrous dysplasia","volume":"94","author":"Thomsen","year":"2014","journal-title":"Calcif Tissue Int"},{"key":"10.4158\/EP-2018-0328_bb0070","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1210\/jc.2003-030050","article-title":"Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone","volume":"88","author":"Plotkin","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0328_bb0075","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1210\/jc.2014-1371","article-title":"A randomized, double blind, placebo-controlled trial of alendronate treatment for fibrous dysplasia of bone","volume":"99","author":"Boyce","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0328_bb0080","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00296-014-3132-x","article-title":"Continuous effect with long-term safety in zoledronic acid therapy for polyostotic fibrous dysplasia with severe bone destruction","volume":"35","author":"Wu","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.4158\/EP-2018-0328_bb0085","doi-asserted-by":"crossref","first-page":"851","DOI":"10.4158\/EP10136.CR","article-title":"Bisphosphonate treatment in polyostotic fibrous dysplasia of the cranium: case report and literature review","volume":"16","author":"Mansoori","year":"2010","journal-title":"Endocr Pract"},{"key":"10.4158\/EP-2018-0328_bb0090","doi-asserted-by":"crossref","first-page":"901","DOI":"10.14740\/jocmr2318w","article-title":"Zoledronate therapy for the pathological humeral fracture in polyostotic fibrous dysplasia: a case report","volume":"7","author":"Ohno","year":"2015","journal-title":"J Clin Med Res"},{"key":"10.4158\/EP-2018-0328_bb0095","first-page":"2329483","article-title":"Use of zoledronic acid in paediatric craniofacial fibrous dysplasia","volume":"2016","author":"Di Pede","year":"2016","journal-title":"Case Rep Pediatr"},{"key":"10.4158\/EP-2018-0328_bb0100","first-page":"487","article-title":"Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years &lsqb;in Chinese]","volume":"47","author":"Li","year":"2009","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.4158\/EP-2018-0328_bb0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.berh.2007.11.004","article-title":"Fibrous dysplasia of bone and McCune-Albright syndrome","volume":"22","author":"Chapurlat","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.4158\/EP-2018-0328_bb0110","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1359\/jbmr.070511","article-title":"Onset, progression, and plateau of skeletal lesions in fibrous dysplasia and the relationship to functional outcome","volume":"22","author":"Hart","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP-2018-0328_bb0115","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S8756-3282(03)00064-4","article-title":"Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression","volume":"33","author":"Riminucci","year":"2003","journal-title":"Bone"},{"key":"10.4158\/EP-2018-0328_bb0120","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/jbmr.2999","article-title":"Outcome of long-term bisphosphonate therapy in McCune-Albright syndrome and polyostotic fibrous dysplasia","volume":"32","author":"Majoor","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP-2018-0328_bb0125","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1359\/JBMR.041111","article-title":"An instrument to measure skeletal burden and predict functional outcome in fibrous dysplasia of bone","volume":"20","author":"Collins","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP-2018-0328_bb0130","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1359\/jbmr.1997.12.10.1746","article-title":"Long-term effects of intravenous pamidronate in fibrous dysplasia of bone","volume":"12","author":"Chapurlat","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP-2018-0328_bb0135","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.curtheres.2009.03.003","article-title":"Long-term pamidronate treatment of polyostotic fibrous dysplasia of bone: a case series in young adults","volume":"70","author":"Parisi","year":"2009","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.4158\/EP-2018-0328_bb0140","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s12098-011-0521-y","article-title":"Recurrent femur neck fracture and response to bisphosphonates in polyostotic fibrous dysplasia","volume":"79","author":"Rastogi","year":"2012","journal-title":"Indian J Pediatr"},{"issue":"suppl 3","key":"10.4158\/EP-2018-0328_bb0145","first-page":"929","article-title":"Pamidronate treatment in bone fibrous dysplasia in children and adolescents with McCune-Albright syndrome","volume":"15","author":"Matarazzo","year":"2002","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.4158\/EP-2018-0328_bb0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1515\/JPEM.2006.19.1.75","article-title":"Pamidronate treatment of polyostotic fibrous dysplasia: failure to prevent expansion of dysplastic lesions during childhood","volume":"19","author":"Chan","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"6 suppl 21","key":"10.4158\/EP-2018-0328_bb0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/sonc.2002.37421","article-title":"Preclinical pharmacology of zoledronic acid","volume":"29","author":"Green","year":"2002","journal-title":"Semin Oncol"},{"key":"10.4158\/EP-2018-0328_bb0160","first-page":"670809","article-title":"Characteristics and treatment results of 5 patients with fibrous dysplasia and review of the literature","volume":"2015","author":"Ozdemir Kutbay","year":"2015","journal-title":"Case Rep Endocrinol"},{"issue":"suppl 2","key":"10.4158\/EP-2018-0328_bb0165","doi-asserted-by":"crossref","first-page":"P114","DOI":"10.1359\/jbmr.06s222","article-title":"Medical therapy in adults with fibrous dysplasia of bone","volume":"21","author":"Chapurlat","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP-2018-0328_bb0170","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.joms.2016.04.001","article-title":"Fibrous dysplasia and medication-related osteonecrosis of the jaw","volume":"74","author":"Metwally","year":"2016","journal-title":"J Oral Maxillofac Surg"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20359395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20359395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:07:56Z","timestamp":1761516476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20359395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1530891X20359395"],"URL":"https:\/\/doi.org\/10.4158\/ep-2018-0328","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Bisphosphonate Therapy in Mccune-Albright Syndrome\u2013Related Polyostotic Fibrous Dysplasia: A Single-Center Experience","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2018-0328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}